128 related articles for article (PubMed ID: 16678479)
21. Taraxasterol from
Sang R; Yu Y; Ge B; Xu L; Wang Z; Zhang X
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3929-3937. PubMed ID: 31571510
[TBL] [Abstract][Full Text] [Related]
22. Pretreatment with propylene glycol alginate sodium sulfate ameliorated concanavalin A-induced liver injury by regulating the PI3K/Akt pathway in mice.
Xu S; Wu L; Zhang Q; Feng J; Li S; Li J; Liu T; Mo W; Wang W; Lu X; Yu Q; Chen K; Xia Y; Lu J; Xu L; Zhou Y; Fan X; Guo C
Life Sci; 2017 Sep; 185():103-113. PubMed ID: 28774703
[TBL] [Abstract][Full Text] [Related]
23. Opposite effects of high and low doses of interleukin-2 on T cell-mediated hepatitis in mice (interleukin-2 on hepatitis).
Zhang X; Wei HX; Rui S; Wei H; Tian Z
Hepatol Int; 2010 Jul; 4(3):641-8. PubMed ID: 21063489
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic advantage of anti-VAP-1 over anti-α4 integrin antibody in concanavalin a-induced hepatitis.
Lee WY; Salmi M; Kelly MM; Jalkanen S; Kubes P
Hepatology; 2013 Oct; 58(4):1413-23. PubMed ID: 23686782
[TBL] [Abstract][Full Text] [Related]
25. Possible changes in expression of chemotaxin LECT2 mRNA in mouse liver after concanavalin A-induced hepatic injury.
Segawa Y; Itokazu Y; Inoue N; Saito T; Suzuki K
Biol Pharm Bull; 2001 Apr; 24(4):425-8. PubMed ID: 11305608
[TBL] [Abstract][Full Text] [Related]
26. Effect of 2-amino-2-(2-(4-octylphenyl) ethyl) propane-1,3-diol hydrochloride (FTY 720) on immune liver injury in mice.
He JH; Zhang HN; Lin ZB
World J Gastroenterol; 2005 Jan; 11(4):573-6. PubMed ID: 15641148
[TBL] [Abstract][Full Text] [Related]
27. The differential effects of low dose and high dose concanavalin A on cytokine profile and their importance in liver injury.
Xu X; Wei H; Dong Z; Chen Y; Tian Z
Inflamm Res; 2006 Apr; 55(4):144-52. PubMed ID: 16807695
[TBL] [Abstract][Full Text] [Related]
28. [Protective effects of artesunate against Con A-induced autoimmune liver injury in mice].
Cao J; Zhao X; Liu MJ; Zheng H; Li JG
Zhongguo Zhong Yao Za Zhi; 2018 May; 43(10):2123-2128. PubMed ID: 29933681
[TBL] [Abstract][Full Text] [Related]
29. The protective action of scutellarin against immunological liver injury induced by concanavalin A and its effect on pro-inflammatory cytokines in mice.
Tan ZH; Yu LH; Wei HL; Liu GT
J Pharm Pharmacol; 2007 Jan; 59(1):115-21. PubMed ID: 17227628
[TBL] [Abstract][Full Text] [Related]
30. Concanavalin A-induced hepatitis in mice is prevented by interleukin (IL)-10 and exacerbated by endogenous IL-10 deficiency.
Di Marco R; Xiang M; Zaccone P; Leonardi C; Franco S; Meroni P; Nicoletti F
Autoimmunity; 1999 Oct; 31(2):75-83. PubMed ID: 10680745
[TBL] [Abstract][Full Text] [Related]
31. IL-6, IFN-gamma and TNF-alpha production by liver-associated T cells and acute liver injury in rats administered concanavalin A.
Cao Q; Batey R; Pang G; Russell A; Clancy R
Immunol Cell Biol; 1998 Dec; 76(6):542-9. PubMed ID: 9893032
[TBL] [Abstract][Full Text] [Related]
32. Protectin D1 reduces concanavalin A-induced liver injury by inhibiting NF-κB-mediated CX3CL1/CX3CR1 axis and NLR family, pyrin domain containing 3 inflammasome activation.
Ren J; Meng S; Yan B; Yu J; Liu J
Mol Med Rep; 2016 Apr; 13(4):3627-38. PubMed ID: 26955849
[TBL] [Abstract][Full Text] [Related]
33. A selective adenosine A2A receptor agonist, ATL-146e, prevents concanavalin A-induced acute liver injury in mice.
Odashima M; Otaka M; Jin M; Horikawa Y; Matsuhashi T; Ohba R; Linden J; Watanabe S
Biochem Biophys Res Commun; 2006 Sep; 347(4):949-54. PubMed ID: 16859640
[TBL] [Abstract][Full Text] [Related]
34. [Effect of ronggan mixture on immunoregulation and hepatocyte apoptosis-related factors in concanavalin A induced acute immunological liver injury mice].
Zhang YQ; Tang XD; Wang FY; Yang B; Liu YL; Guo P; Wang P; Bian LQ; Zhao YP
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Nov; 33(11):1500-6. PubMed ID: 24483111
[TBL] [Abstract][Full Text] [Related]
35. Role of CpG ODN in concanavalin A-induced hepatitis in mice.
Abe K; Ohira H; Kobayashi H; Rai T; Saito H; Takahashi A; Sato Y
Fukushima J Med Sci; 2005 Jun; 51(1):41-9. PubMed ID: 16167672
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of phosphodiesterase 7A ameliorates Concanavalin A-induced hepatitis in mice.
Goto M; Tanaka Y; Murakawa M; Kadoshima-Yamaoka K; Inoue H; Murafuji H; Nagahira A; Kanki S; Hayashi Y; Nagahira K; Ogata A; Miura K; Nakatsuka T; Chamoto K; Fukuda Y; Nishimura T
Int Immunopharmacol; 2009 Oct; 9(11):1347-51. PubMed ID: 19671449
[TBL] [Abstract][Full Text] [Related]
37. Paeoniflorin protects against concanavalin A-induced hepatitis in mice.
Chen M; Cao L; Luo Y; Feng X; Sun L; Wen M; Peng S
Int Immunopharmacol; 2015 Jan; 24(1):42-9. PubMed ID: 25479726
[TBL] [Abstract][Full Text] [Related]
38. Fucoidan reduces inflammatory response in a rat model of hepatic ischemia-reperfusion injury.
Li XJ; Ye QF
Can J Physiol Pharmacol; 2015 Nov; 93(11):999-1005. PubMed ID: 26485583
[TBL] [Abstract][Full Text] [Related]
39. Effect of diphenyl dimethyl bicarboxylate on concanavalin A-induced liver injury in mice.
Gao M; Zhang J; Liu G
Liver Int; 2005 Aug; 25(4):904-12. PubMed ID: 15998443
[TBL] [Abstract][Full Text] [Related]
40. Induction of thymocyte apoptosis by systemic administration of concanavalin A in mice: role of TNF-alpha, IFN-gamma and glucocorticoids.
Fayad R; Sennello JA; Kim SH; Pini M; Dinarello CA; Fantuzzi G
Eur J Immunol; 2005 Aug; 35(8):2304-12. PubMed ID: 16047339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
